Amgen Stock Options

AMGN Stock  USD 313.71  1.07  0.34%   
Amgen's latest option contracts expiring on June 20th 2025 are carrying combined implied volatility of 0.42 with a put-to-call open interest ratio of 0.45 over 71 outstanding agreements suggesting investors are buying more calls than puts on contracts expiring on June 20th 2025. The total put volume is at K, with calls trading at the volume of 2.3 K. This yields a 0.86 put-to-call volume ratio.

Open Interest Against June 20th 2025 Option Contracts

The chart above shows Amgen's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Amgen's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Amgen's option, there is no secondary market available for investors to trade.

Amgen Maximum Pain Price Across 2025-06-20 Option Contracts

Max pain occurs when Amgen's market makers reach a net positive position across all Amgen's options at a strike price where option holders stand to lose the most money. By contrast, Amgen's option sellers may reap the most after selling more options than buying, causing them to expire worthless.

In The Money vs. Out of Money Option Contracts on Amgen

Analyzing Amgen's in-the-money options over time can help investors to take a profitable long position in Amgen regardless of its overall volatility. This is especially true when Amgen's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Amgen's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Amgen's stock while costing only a fraction of its price.
Please note that buying 'in-the-money' options on Amgen lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Amgen's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Amgen contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Amgen Stock moves the wrong way.

Amgen Inc In The Money Call Balance

When Amgen's strike price is surpassing the current stock price, the option contract against Amgen Inc stock is said to be in the money. When it comes to buying Amgen's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Amgen Inc are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Amgen Current Options Market Mood

Amgen's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Amgen Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most Amgen's options investors are not very successful. Amgen's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Amgen contract

Base on the Rule 16, the options market is currently suggesting that Amgen Inc will have an average daily up or down price movement of about 0.0263% per day over the life of the 2025-06-20 option contract. With Amgen trading at USD 313.71, that is roughly USD 0.0823. If you think that the market is fully incorporating Amgen's daily price movement you should consider buying Amgen Inc options at the current volatility level of 0.42%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing Amgen options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Amgen calls. Remember, the seller must deliver Amgen Inc stock to the call owner when a call is exercised.

Amgen Option Chain

When Amgen's strike price is surpassing the current stock price, the option contract against Amgen Inc stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Amgen's option chain is a display of a range of information that helps investors for ways to trade options on Amgen. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Amgen. It also shows strike prices and maturity days for a Amgen against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
AMGN250620C005000004500.00.0 - 2.160.3Out
Call
AMGN250620C004900000490.00.0 - 2.172.17Out
Call
AMGN250620C004800000480.00.0 - 2.182.18Out
Call
AMGN250620C0047000013470.00.0 - 2.191.22Out
Call
AMGN250620C004600007460.00.0 - 2.21.09Out
Call
AMGN250620C0045000020450.00.0 - 2.230.2Out
Call
AMGN250620C0044000073440.00.05 - 2.271.84Out
Call
AMGN250620C00430000475430.00.0 - 1.160.79Out
Call
AMGN250620C0042000081420.00.02 - 2.380.29Out
Call
AMGN250620C00410000140410.00.09 - 1.951.41Out
Call
AMGN250620C004000001341400.00.12 - 1.850.7Out
Call
AMGN250620C00390000102390.00.28 - 1.170.97Out
Call
AMGN250620C00380000184380.01.07 - 1.261.11Out
Call
AMGN250620C00370000372370.01.71 - 1.91.6Out
Call
AMGN250620C00360000524360.02.61 - 2.942.85Out
Call
AMGN250620C003500008906350.03.6 - 4.54.3Out
Call
AMGN250620C00340000440340.05.45 - 6.757.45Out
Call
AMGN250620C00330000341330.08.6 - 9.99.68Out
Call
AMGN250620C003200001127320.013.15 - 14.0512.86Out
Call
AMGN250620C00310000326310.018.6 - 19.7521.45In
Call
AMGN250620C003000003414300.023.95 - 25.5524.4In
Call
AMGN250620C00290000273290.030.95 - 32.6531.76In
Call
AMGN250620C00280000377280.039.35 - 40.738.75In
Call
AMGN250620C00270000223270.046.65 - 49.360.0In
Call
AMGN250620C00260000146260.056.75 - 58.970.08In
Call
AMGN250620C00250000193250.066.15 - 68.1563.75In
Call
AMGN250620C0024000024240.074.85 - 78.566.48In
Call
AMGN250620C002300005230.084.6 - 88.256.3In
Call
AMGN250620C0022000031220.094.0 - 97.975.25In
Call
AMGN250620C002100002210.0104.3 - 107.7554.7In
Call
AMGN250620C0020000038200.0114.1 - 117.8123.34In
Call
AMGN250620C0019500015195.0118.55 - 122.3109.05In
 Put
AMGN250620P005000000500.0184.8 - 188.05184.8In
 Put
AMGN250620P004900000490.0174.15 - 178.05174.15In
 Put
AMGN250620P004800000480.0164.15 - 168.0164.15In
 Put
AMGN250620P004700000470.0154.2 - 158.0154.2In
 Put
AMGN250620P004600000460.0144.25 - 148.0144.25In
 Put
AMGN250620P004500000450.0134.25 - 138.05134.25In
 Put
AMGN250620P004400000440.0124.15 - 128.05124.15In
 Put
AMGN250620P004300000430.0114.3 - 118.0114.3In
 Put
AMGN250620P004200000420.0104.2 - 107.95104.2In
 Put
AMGN250620P004100000410.094.3 - 98.094.3In
 Put
AMGN250620P003600001360.046.75 - 48.5541.73In
 Put
AMGN250620P003500005350.038.55 - 40.251.15In
 Put
AMGN250620P00340000103340.030.95 - 32.022.24In
 Put
AMGN250620P00330000118330.024.3 - 25.4523.72In
 Put
AMGN250620P00320000191320.018.3 - 19.3519.1In
 Put
AMGN250620P00310000293310.013.5 - 14.914.0Out
 Put
AMGN250620P00300000900300.09.6 - 10.99.6Out
 Put
AMGN250620P00290000696290.06.6 - 7.856.8Out
 Put
AMGN250620P00280000645280.04.4 - 5.74.67Out
 Put
AMGN250620P00270000776270.02.92 - 3.33.2Out
 Put
AMGN250620P002600001247260.01.9 - 2.332.67Out
 Put
AMGN250620P00250000943250.01.25 - 1.561.6Out
 Put
AMGN250620P00240000466240.00.95 - 2.311.25Out
 Put
AMGN250620P00230000280230.00.65 - 1.00.97Out
 Put
AMGN250620P00220000146220.00.23 - 1.980.77Out
 Put
AMGN250620P00210000357210.00.43 - 2.80.64Out
 Put
AMGN250620P002000001092200.00.4 - 1.550.65Out
 Put
AMGN250620P0019500049195.00.1 - 2.21.06Out
 Put
AMGN250620P0019000048190.00.01 - 2.650.91Out
 Put
AMGN250620P00185000105185.00.02 - 2.480.85Out
 Put
AMGN250620P0018000010180.00.01 - 2.050.92Out
 Put
AMGN250620P001750005175.00.02 - 2.420.6Out
 Put
AMGN250620P0017000082170.00.02 - 2.530.75Out
 Put
AMGN250620P001650009165.00.0 - 2.50.4Out
 Put
AMGN250620P0016000031160.00.0 - 2.470.44Out
 Put
AMGN250620P001550001155.00.0 - 2.452.15Out
 Put
AMGN250620P001500006150.00.0 - 2.421.02Out
 Put
AMGN250620P001450001145.00.0 - 2.41.6Out
 Put
AMGN250620P001400001140.00.0 - 2.370.27Out

Amgen Selling And Marketing Expenses Over Time

   Selling And Marketing Expenses   
       Timeline  

Amgen Market Cap Over Time

   Market Cap   
       Timeline  

Amgen Total Stockholder Equity

Total Stockholder Equity

5.58 Billion

At this time, Amgen's Total Stockholder Equity is very stable compared to the past year.

Amgen Corporate Management

Jonathan JDGeneral VPProfile
Linda LouieVP OfficerProfile
James MDExecutive OfficerProfile
Nancy GrygielSenior OfficerProfile
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amgen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.19)
Dividend Share
9
Earnings Share
7.56
Revenue Per Share
62.242
Quarterly Revenue Growth
0.109
The market value of Amgen Inc is measured differently than its book value, which is the value of Amgen that is recorded on the company's balance sheet. Investors also form their own opinion of Amgen's value that differs from its market value or its book value, called intrinsic value, which is Amgen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amgen's market value can be influenced by many factors that don't directly affect Amgen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amgen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.